Wellington Management Group LLP reduced its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 19.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 402,880 shares of the health services provider's stock after selling 97,699 shares during the quarter. Wellington Management Group LLP owned about 0.67% of Maximus worth $37,532,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Quadrature Capital Ltd grew its stake in Maximus by 6.0% during the 3rd quarter. Quadrature Capital Ltd now owns 10,934 shares of the health services provider's stock valued at $1,018,000 after purchasing an additional 621 shares during the last quarter. Quarry LP increased its stake in shares of Maximus by 48.0% in the third quarter. Quarry LP now owns 1,017 shares of the health services provider's stock worth $95,000 after acquiring an additional 330 shares during the period. Petrus Trust Company LTA increased its stake in shares of Maximus by 2.7% in the third quarter. Petrus Trust Company LTA now owns 7,084 shares of the health services provider's stock worth $660,000 after acquiring an additional 185 shares during the period. Holocene Advisors LP raised its holdings in shares of Maximus by 6.5% during the third quarter. Holocene Advisors LP now owns 3,927 shares of the health services provider's stock worth $366,000 after purchasing an additional 239 shares during the last quarter. Finally, Verition Fund Management LLC lifted its position in Maximus by 83.3% during the third quarter. Verition Fund Management LLC now owns 8,331 shares of the health services provider's stock valued at $776,000 after purchasing an additional 3,786 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.
In related news, insider Michelle F. Link sold 1,363 shares of Maximus stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total value of $126,159.28. Following the completion of the transaction, the insider now owns 6,567 shares in the company, valued at $607,841.52. The trade was a 17.19 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.40% of the company's stock.
Separately, StockNews.com downgraded Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, November 28th.
Get Our Latest Stock Report on Maximus
Shares of MMS stock opened at $70.67 on Friday. Maximus, Inc. has a twelve month low of $70.00 and a twelve month high of $93.97. The stock has a market cap of $4.26 billion, a P/E ratio of 14.13 and a beta of 0.73. The stock has a 50 day moving average of $83.01 and a 200 day moving average of $86.70. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59.
The company also recently announced a quarterly dividend, which was paid on Saturday, November 30th. Stockholders of record on Friday, November 15th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.70%. The ex-dividend date was Friday, November 15th. Maximus's dividend payout ratio (DPR) is 24.00%.
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.